Northwestern Mutual Wealth Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25	Closed	-$655	–	3642
2022 Q4	$655	Buy	+25	New	+$554	﹤0.01%	3097
2017 Q1	–	Sell	-4	Closed	–	–	2485
2016 Q4	$0	Buy	+4	New	+$242	﹤0.01%	2394
2016 Q3	–	Sell	-47	Closed	-$2K	–	1643
2016 Q2	$2K	Buy	+47	New	+$2.86K	﹤0.01%	1881

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Northwestern Mutual Wealth Management's KDNY Position: Q1 2023 in Review

Northwestern Mutual Wealth Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2023, closing a stake of 25 shares — an estimated $655 sold.

Northwestern Mutual Wealth Management first reported a position in KDNY in Q2 2016 and held it in 3 quarters. The position peaked at $2K in Q2 2016. 157 funds tracked by Wall St. Rank hold KDNY as of Q1 2023.

Northwestern Mutual Wealth Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 25 Chinook Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $655.
Northwestern Mutual Wealth Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
Northwestern Mutual Wealth Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2016.
157 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.